March 26, 2012
JPM Pullback Toward Expected Cycle Low Due? -- Donald W. Pendergast, Jr.
After plunging by 45% between February and October 2010, shares of JPMorgan Chase have rebounded sharply. However, prices may soon be due for a pullback over the next month or so....
(more)
So Are We Seeing A Correction Soon? -- Koos van der Merwe
The bears haven't given up, even as the market is moving to new highs every day. But what lies around the corner?...
(more)
March 23, 2012
AAPL's Faltering Money Flow -- Donald W. Pendergast, Jr.
With shares of Apple Inc. now going nearly vertical, it's time to take a step back and look at the big picture....
(more)
DECK In Intermediate Downtrend -- Chaitali Mohile
The long-term uptrend of Deckers Outdoor Corp. has entered an intermediate downtrend....
(more)
March 22, 2012
Is The Cycle High For .RUT? -- Donald W. Pendergast, Jr.
The R2K just broke higher out of an inverted head & shoulders pattern, but is this rally attempt too little, too late?...
(more)
How To Profit In The Short Term -- Billy Williams
The bull run is still climbing, and you can use this unique pattern in the short term to help you pile up the profits....
(more)
March 21, 2012
Strength Of Reversal Candlestick Pattern -- Chaitali Mohile
Although certain candlestick formations are commonly found on technical charts, they do affect the price rally....
(more)
Overbought Stock Market Doesn't Mean Sell -- Mike Carr, CMT
Traders often assume overbought markets are ready to decline, but as the S&P 500 has shown in 2012, markets can stay overbought for extended periods....
(more)
March 20, 2012
Three Tips For Trading Consolidation Points -- Billy Williams
Points of price consolidation offer you a chance for a great entry into a fast-moving stock, and these three tips will help you time your entries with greater precision and possibly higher profits....
(more)
Market Taking A Bite Out Of Apple? -- Donald W. Pendergast, Jr.
In a mammoth runup, how much higher does Apple really have left to run?...
(more)
March 19, 2012
The Road Ahead -- Billy Williams
Despite a cynical outlook as 2012 began, the market has steadily risen but with pessimism in the air. The question remains: What lies on the road ahead?...
(more)
NMM Stuck In Narrow Range -- Chaitali Mohile
Navios Maritime Partners is likely to turn weaker in the long run....
(more)
March 16, 2012
Looking For Buy & Hold -- Koos van der Merwe
Looking to buy & hold? Here are two stocks you may be interested in....
(more)
Get The Big Menu With Darden Restaurants -- Donald W. Pendergast, Jr.
Shares of Darden Restaurants appear ready to move higher from a recent breakout pattern, but traders need to take a good look at other technicals before they go long....
(more)
March 15, 2012
TSO Movin' On Up? -- Donald W. Pendergast, Jr.
Shares of Tesoro Corp. are poised to make an attempt to make a new multimonth high -- if the broad market cooperates....
(more)
$COMPQ At New High -- Chaitali Mohile
Recently, $COMPQ breached historical resistance. Can a small bearish rally discourage the bullish breakout?...
(more)
March 14, 2012
S&P 500 Support Levels To Watch -- Donald W. Pendergast, Jr.
After such a big run higher, it's not surprising that the .SPX is due for a breather. Just how big a decline awaits may be determined by its strongest support levels....
(more)
How To Play The Turns In The Market -- Billy Williams
The trend is your friend, but navigating the turns in the market can help you make larger returns by catching tops and bottoms at just the right moment....
(more)
March 13, 2012
.DXY Ready For A Swing Up? -- Donald W. Pendergast, Jr.
Contrary to what many hard-money devotees may believe, the US dollar may not be all washed up after all....
(more)
Trading A 1-2-3 Trend Reversal -- Ron Walker
Spotting a trend reversal is as easy as 1-2-3....
(more)
March 12, 2012
Yahoo Prospects Are Rising -- Billy Williams
Yahoo has seen better days, but its prospects are on the rise as big moves in technology brew and two giants begin to battle it out....
(more)
Pfizer In Statistical Analysis -- Alan R. Northam
Statistical analysis is used to show that Pfizer is in the process of reversing its intermediate-term trend from up to down....
(more)
...More Articles